1. Actin-Like Protein 8 Promotes the Progression of Triple-Negative Breast Cancer via Activating PI3K/AKT/mTOR Pathway
   Shaoxia Fan et al, 2021, OTT CrossRef
2. The involvement of epithelial-to-mesenchymal transition in doxorubicin resistance: Possible molecular targets
   Sepideh Mirzaei et al, 2021, European Journal of Pharmacology CrossRef
3. Radix Tetrastigma extracts enhance the chemosensitivity in triple-negative breast cancer via inhibiting PI3K/Akt/mTOR-mediated autophagy
   Shuo Zhang et al, 2021, Clinical Breast Cancer CrossRef
4. ERβ in Triple-Negative Breast Cancer: Emerging Concepts and Therapeutic Possibilities
   Alessandra Monaco et al, 2021, Endocrines CrossRef
5. Light at night and risk of breast cancer: a systematic review and dose-response meta-analysis.
   Marco Vinceti, 0 CrossRef
6. Sex Hormones in Breast Cancer Immunity
   Ebony Hargrove-Wiley et al, 2023 CrossRef
7. Modeling the effects of genetic- and diet-induced obesity on melanoma progression in zebrafish
   Emily Montal et al, 2023 CrossRef
8. null
   Pia Giovannelli et al, 2023 CrossRef
9. Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming
   Roberto Mattioli et al, 2023, Molecular Aspects of Medicine CrossRef
10. Current progress and prospects for G protein-coupled estrogen receptor in triple-negative breast cancer
    Duo Zhang et al, 2024, Front. Cell Dev. Biol. CrossRef
11. Protecting the Brain: Novel Strategies for Preventing Breast Cancer Brain Metastases through Selective Estrogen Receptor β Agonists and In Vitro Blood–Brain Barrier Models
    Janine Kirchner et al, 2024, IJMS CrossRef